Expansion capacity Perceptive's Needham expansion and upgraded in vitro lab capabilities create opportunities to onboard more preclinical oncology programs and accelerate isotope imaging studies for sponsors.

Radiopharma leadership The launch of α-Sight and the MH3D collaboration position Perceptive to offer advanced alpha radiopharmaceutical imaging and isotope datasets to oncology and radiopharma clients, enabling new study designs.

Strategic collaborations Recent partnerships with Certis Oncology, Trialzen, and MH3D illustrate a pattern of integrated solutions across discovery to development, enabling joint offerings in imaging, RTSM, analytics, and eClinical.

Clinical Intelligence Perceptive Clinical Intelligence introduces a new service line focused on forecasting, supply management, and IRT-enabled eClinical, creating cross-sell opportunities within existing client programs.

End to end With imaging biomarkers, core lab services, software, and analytics spanning the full R&D lifecycle, the company can offer unified data generation and trial operations to pharma and biotech customers.